Skip to search formSkip to main contentSkip to account menu

mystixin 7

Known as: 4-anisoyl-arginyl-lysyl-leucyl-leucyl-thienyl-isoleucyl-leucinamide, mystixin-7, p-anisoyl-Arg-Lys-Leu-Leu-Thi-Ile-Leu-NH2 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Anti-ictogenic effects of the corticotropin-releasing factor-like peptide in the pentylenetetrazole model of seizure in brain slices
2014
2014
Corticotropin-releasing factor-like peptide modifies the AMPA-, NMDA-dependent and GABAB-ergic properties of synaptic transmissions in vitro
2000
2000
Lowering of interstitial fluid pressure after neurogenic inflammation is inhibited by mystixin-7 peptide.
Soft tissue injury is accompanied by lowering of interstitial fluid pressure (P(if)), plasma protein extravasation, and edema… 
1998
1998
Anti-inflammatory mystixin peptides inhibit plasma leakage without blocking endothelial gap formation.
Mystixins are synthetic peptides that inhibit plasma leakage after tissue injury. We sought to determine the mechanism of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)